|
USP37 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.861000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.353600E-02 |
| Normal-vs-Stage2 |
6.187600E-01 |
| Normal-vs-Stage3 |
2.811400E-01 |
| Normal-vs-Stage4 |
5.729700E-02 |
| Stage1-vs-Stage2 |
4.515600E-01 |
| Stage1-vs-Stage3 |
3.658000E-03 |
| Stage1-vs-Stage4 |
2.383700E-04 |
| Stage2-vs-Stage3 |
2.091000E-01 |
| Stage2-vs-Stage4 |
7.779600E-02 |
| Stage3-vs-Stage4 |
4.456200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.816800E-01 |
| Normal-vs-AfricanAmerican |
4.194100E-02 |
| Normal-vs-Asian |
4.350800E-01 |
| Caucasian-vs-AfricanAmerican |
4.557300E-03 |
| Caucasian-vs-Asian |
5.177400E-01 |
| AfricanAmerican-vs-Asian |
6.473800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.197400E-01 |
| Normal-vs-Female |
3.938100E-02 |
| Male-vs-Female |
4.238400E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.094400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.504170E-01 |
| Normal-vs-Age(61-80Yrs) |
9.312400E-01 |
| Normal-vs-Age(81-100Yrs) |
6.332600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.242500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.452600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.946000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.051180E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.022600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.489000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.127030E-01 |
| Normal-vs-Grade 2 |
1.209570E-02 |
| Normal-vs-Grade 3 |
6.626000E-01 |
| Normal-vs-Grade 4 |
7.602800E-04 |
| Grade 1-vs-Grade 2 |
5.131000E-01 |
| Grade 1-vs-Grade 3 |
4.607800E-02 |
| Grade 1-vs-Grade 4 |
3.632900E-04 |
| Grade 2-vs-Grade 3 |
2.238000E-03 |
| Grade 2-vs-Grade 4 |
2.61360000308741E-08 |
| Grade 3-vs-Grade 4 |
3.482100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.75090000004352E-06 |
| Normal-vs-ccB subtype |
1.323690E-02 |
| ccA subtype-vs-ccB subtype |
4.47875070364034E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.775000E-01 |
| Normal-vs-N1 |
5.540000E-01 |
| N0-vs-N1 |
4.275000E-01 |
|
|
